NCT00305630View on ClinicalTrials.gov

Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

November 30, 2005

Conditions
Choroidal NeovascularizationAge-Related Macular Degeneration
Interventions
DRUG

Periocular injection of triamcinolone acetonide 40mg

Trial Locations (2)

21287

Johns Hopkins Univeristy School of Medicine, Baltimore

97239

Oregon Health Science Univeristy, Portland

All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

lead

Johns Hopkins University

OTHER

NCT00305630 - Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT) | Biotech Hunter | Biotech Hunter